Evidence map›Paper›PMID 34012024›Full record

ArticleScientific reports2021

Towards water-soluble [60]fullerenes for the delivery of siRNA in a prostate cancer model.

Julia Korzuch, Monika Rak, Katarzyna Balin, Maciej Zubko, Olga Głowacka, Mateusz Dulski, Robert Musioł, Zbigniew Madeja, Maciej Serda

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Research Progress of Hydrogel Microneedles in Wound Management.ACS biomaterials science & engineering · 2024
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. ACS biomaterials science & engineering · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Julia Korzuch *Institute of Chemistry, University of Silesia in Katowice, 40-006, Katowice, Poland.
Monika Rak *Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387, Kraków, Poland.
Katarzyna BalinInstitute of Physics and Silesian Center for Education and Interdisciplinary Research, University of Silesia in Katowice, 41-500, Chorzów, Poland.
Maciej ZubkoInstitute of Materials Engineering, University of Silesia in Katowice, 41-500, Chorzów, Poland.
Olga GłowackaFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387, Kraków, Poland.
Mateusz DulskiInstitute of Materials Engineering, University of Silesia in Katowice, 41-500, Chorzów, Poland.
Robert MusiołInstitute of Chemistry, University of Silesia in Katowice, 40-006, Katowice, Poland.
Zbigniew MadejaFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387, Kraków, Poland.
Maciej SerdaInstitute of Chemistry, University of Silesia in Katowice, 40-006, Katowice, Poland. maciej.serda@us.edu.pl.
University of Silesia in Katowice · PLJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents two water-soluble fullerene nanomaterials (HexakisaminoC

Indexed as

Drug Delivery SystemsFullerenesCell Line, TumorDrug Screening Assays, AntitumorHumansLipidsMaleNanostructuresProstatic NeoplasmsRNA, Small InterferingSolubilityFullerenesLipidsLipofectamineRNA, Small Interfering

Identifiers

PMID34012024
PMCPMC8134426
OpenAlexW3160094474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.